Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / ALCAM

ALCAM

Basics

Aliases:
This biomarker is also known as:
  • activated leukocyte cell adhesion molecule,
  • MEMD,
  • MGC71733,
  • CD166,
  • FLJ38514,

Description…

CD166 is a sticky cell adhesion molecule that binds to CD6. It is involved in neurite extension by neurons via heterophilic and homophilic interactions and may play a role in the binding of T- and B-cells to activated leukocytes, as well as in interactions between cells of the nervous system.

Attributes

QA State: Under Review
Type: Protein
Short Name:
HGNC Name: ALCAM

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Biomuta

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.